Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | BBIO | BHC | ||
| Company | Cymabay Therapeutics | Bridgebio Pharma Inc | Bausch Health Companies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 32.49 | 26.04 | 7.33 | ||
| High | 32.50 | 26.90 | 7.60 | ||
| Low | 32.48 | 26.02 | 7.33 | ||
| Last | 32.48 | 26.49 | 7.47 | ||
| Change | +0.01 | +0.28 | +0.08 | ||
| % Change | +0.03% | +1.07% | +1.08% | ||
| Volume | 8,356,200 | 4,196,300 | 1,232,900 | ||
| 20-Day Average Volume | 3,390,805 | 2,701,745 | 1,442,085 | ||
| Previous Close | 32.47 | 26.21 | 7.39 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 27.21 | 7.90 | ||
| 20-Day Raw Stochastic | 94.12% | 50.00% | 11.81% | ||
| 20-Day Relative Strength | 78.00% | 50.43% | 41.67% | ||
| Weighted Alpha | +247.60 | -29.24 | -8.68 | ||
| Today's Opinion | 100% Buy | 8% Buy | 8% Sell | ||
| Previous Opinion | 100% Buy | 8% Sell | 8% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | -3.64% since 12/13/24 | -4.35% since 12/13/24 | ||
| Low | 32.44 on 03/15/24 | 25.34 on 12/19/24 | 7.33 on 12/20/24 | ||
| High | 32.50 on 03/21/24 | 28.18 on 12/16/24 | 7.83 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | +14.97% since 11/20/24 | -8.79% since 11/20/24 | ||
| Low | 32.15 on 02/22/24 | 22.47 on 11/22/24 | 7.33 on 12/20/24 | ||
| High | 32.50 on 03/21/24 | 30.51 on 11/25/24 | 8.52 on 12/10/24 | ||
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | -0.93% since 09/20/24 | -6.97% since 09/20/24 | ||
| Low | 22.11 on 01/26/24 | 21.72 on 11/19/24 | 7.33 on 12/20/24 | ||
| High | 32.50 on 03/21/24 | 30.51 on 11/25/24 | 9.85 on 11/04/24 | ||
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | -2.07% since 06/20/24 | +11.00% since 06/20/24 | ||
| Low | 12.32 on 10/13/23 | 21.62 on 06/24/24 | 3.96 on 07/24/24 | ||
| High | 32.50 on 03/21/24 | 32.06 on 09/05/24 | 9.85 on 11/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 5,006,346 | 2,701,384 | ||
| Shares Outstanding, K | 114,724 | 188,990 | 361,631 | ||
| Annual Sales | 31,070,000 | 9,300,000 | 8,757,000,000 | ||
| Annual Net Income | -105,370,000 | -643,200,000 | -592,000,000 | ||
| Last Quarter Sales | 60,000 | 2,730,000 | 2,510,000,000 | ||
| Last Quarter Net Income | -41,900,000 | -162,040,000 | -85,000,000 | ||
| 60-Month Beta | 0.32 | 1.08 | 0.69 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | -0.86 on 11/12/24 | 1.12 on 10/30/24 | ||
| Latest Earnings Date | 03/21/24 | 11/14/24 | 10/30/24 | ||
| Most Recent Dividend | N/A | N/A | 1.000 on 11/10/10 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 1.99 | ||